Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status.

Cancer causes & control : CCC - 1 May 2013

Simonsson Maria, Söderlind Viktoria, Henningson Maria, Hjertberg Maria, Rose Carsten, Ingvar Christian, Jernström Helena

Abstract excerpt

PURPOSE: Whether coffee modulates response to endocrine therapy in breast cancer patients is currently unknown. The CYP1A2 and CYP2C8 enzymes contribute to tamoxifen and caffeine metabolism. The purpose was to investigate the impact of coffee consumption on tumor characteristics and risk for early events in relation to breast cancer treatment and CYP1A2 and CYP2C8 genotypes. METHODS: Questionnaires regarding...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to Aryl Hydrocarbon Hydroxylases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Coffee

Share to Cytochrome P-450 CYP1A2

Share to Cytochrome P-450 CYP2C8

Share to Receptors, Estrogen

Share to Tamoxifen

Source

Identifiers

PMID: 23412805
DOI: 10.1007/s10552-013-0169-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status.PMID 23412805Read ↗

Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status.Semantic proximity Read ↗

High coffee intake, but not caffeine, is associated with reduced estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype.Semantic proximity Read ↗

Clinical effects of A4889G and T6235C polymorphisms in cytochrome P-450 CYP1A1 for breast cancer patients treated with tamoxifen: implications for tumor aggressiveness and patient survival.Semantic proximity Read ↗

Association of Coffee Drinking With Mortality by Genetic Variation in Caffeine Metabolism: Findings From the UK Biobank.Semantic proximity Read ↗

CYP1A2--a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients.Semantic proximity Read ↗

Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk.Semantic proximity Read ↗

Effect of CYP2C19 genotypes on tamoxifen metabolism and early-breast cancer relapse.Semantic proximity Read ↗

Coffee and caffeine intake and breast cancer risk: an updated dose-response meta-analysis of 37 published studies.Semantic proximity Read ↗

Association of CYP2C19*2 and associated haplotypes with lower norendoxifen concentrations in tamoxifen-treated Asian breast cancer patients.Semantic proximity Read ↗

The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.Semantic proximity Read ↗

Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

No association found between CYP2D6 genotype and early breast cancer events in tamoxifen-treated patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.